Profile cover photo
Profile photo
OncLive
319 followers -
Bringing the Oncology Community Together
Bringing the Oncology Community Together

319 followers
About
OncLive's posts

Post has attachment
Dr. Tolaney on Platinum-Based Therapy in Neoadjuvant Setting of TNBC http://ow.ly/PLtgE

Post has attachment
Frontline Nivolumab Improves Survival in Phase III Melanoma Study http://ow.ly/z1z5j

Post has attachment
Two Phase III Trials Find Rolapitant Effective, Well-Tolerated for Preventing CINV http://ow.ly/yyQgt

Post has attachment
In 80405 ORR was 67% versus 56% with FOLFOX plus cetuximab and bevacizumab, respectively http://ow.ly/yyPzh

Post has attachment
Resection of the primary tumor followed by systemic treatment yielded a 4.7-month OS benefit in mCRC http://ow.ly/yyGaR

Post has attachment
ODAC voted 11-2 against the accelerated approval of the PARP inhibitor olaparib http://ow.ly/ys9vA

Post has attachment
Dr. Nicholas Vogelzang discusses the addition of docetaxel to first-line ADT in men with prostate cancer http://ow.ly/xQJ9H

Post has attachment
Ramucirumab Modestly Improves Survival in Advanced NSCLC http://ow.ly/xu59z

Post has attachment
Treatment with ibrutinib dramatically increased PFS and OS compared with ofatumumab in relapsed CLL http://ow.ly/xtNty

Post has attachment
Dr. Maha Hussain Discusses the ETS Gene Fusion as a Predictive Biomarker in Prostate Cancer http://ow.ly/xtAwD
Wait while more posts are being loaded